A live EP case presentation during the 2018 Heart Rhythm meeting.
Here is an aggregation of all the news and late-breaking studies presented at the 2018 Heart Rhythm Society (HRS) Scientific Sessions in May.
Late-breaking Studies:
• Prevention of Arrhythmia Device Infection Trial (PADIT) — Novel Antibiotics Can Help Lower EP Device Infection Rates
• Atrial Fibrillation Burden and Impact on Mortality and Hospitalization — The CASTLE-AF Trial
• Intramural Needle Ablation for Refractory Ventricular Arrhythmias: 6-month Safety and Outcomes
• AV Synchronous Pacing with a Ventricular Leadless Pacemaker: Primary Results from the Marvel Study
Other Key Heart Rhythm 2018 News:
Atrial Fibrillation Patients Diagnosed With Carotid Atery Disease Face Increased Risk of Dementia
Five Key Takeaways From Heart Rhythm 2018
Link Found Between Post-Traumatic Stress, Increased Risk of AFib
Marijuana Use Does Not Increase Risk of Arrhythmias, Might Reduce AFib Risk
Exposure to Air Pollution on Cold Days Can Trigger Sudden Cardiac Death in Women
Consumer Smart Watches Accurately Measure Paroxysmal Supraventricular Tachycardia
Radiofrequency Transseptal Needle Associated With 40 Percent Decrease in Silent Cerebral Embolism
FDA Clears Abbott's High-density Advisor HD Grid EP Mapping Catheter
Biosense Webster Launches Carto Vizigo Bi-Directional Guidance Sheath
Online ECG Monitoring Detects Paroxysmal AFib More Effectively Than Holter, Patch Methods
Link to the Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials
Other Late-breaking Cardiology Trials in 2018:
TCT 2018 Late-breaking Cardiovascular Clinical Trials
EuroPCR 2018 Late-breaking Trials in Interventional Cardiology
Heart Rhythm 2018 Late-breaking Studies
SCAI 2018 Late-breaking Clinical Trials
#HRS2018, #HRS18